Study of a new cream for mild to moderate eczema
Treatments studied
This trial tests a new topical medication for eczema, a chronic itchy skin condition. The goal is to see if it improves symptoms and is safe for people with mild to moderate eczema affecting a limited body area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had eczema for at least 6 months and it is currently mild or moderate.
- Your eczema covers 5% to 25% of your body, excluding your scalp, palms, and soles.
- You are willing to use effective contraception during the study and for 3 months after the last dose (if you can become pregnant or father a child).
- You have not used certain eczema treatments recently, like strong steroid creams, oral steroids, or biologics, within specific time frames.
- You do not have active infections, tuberculosis, HIV, hepatitis B or C, or other inflammatory skin conditions that could interfere with the results.
- You agree to limit sunbathing and tanning bed use during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational cream for moderate to severe eczema. It helps see if the cream reduces symptoms like itching and skin inflammation.
This study tests a new medication (IBI3033) for people with moderate to severe atopic dermatitis (eczema) that hasn't responded well to creams. The goal is to see if it's safe and effective in reducing symptoms like itching and rash.
This study tests a new cream (CMS-D001) for people with moderate to severe eczema. Participants will receive either the study cream or a placebo (a cream with no active ingredient) to see if it helps reduce symptoms like itching and redness.
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
This study tests an experimental treatment for people with moderate to severe eczema that has lasted at least a year. It aims to see if the new medicine can help control symptoms better than current options.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
Hear when a new Safety trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.